IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0175721.html

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada

Author

Listed:
  • Thomas E Delea
  • Derek Weycker
  • Mark Atwood
  • Dion Neame
  • Fabián P Alvarez
  • Evelyn Forget
  • Joanne M Langley
  • Ayman Chit

Abstract

Background: Public health programs to prevent invasive meningococcal disease (IMD) with monovalent serogroup C meningococcal conjugate vaccine (MCV-C) and quadrivalent meningococcal conjugate vaccines (MCV-4) in infancy and adolescence vary across Canadian provinces. This study evaluated the cost-effectiveness of various vaccination strategies against IMD using current and anticipated future pricing and recent epidemiology. Methods: A cohort model was developed to estimate the clinical burden and costs (CAN$2014) of IMD in the Canadian population over a 100-year time horizon for three strategies: (1) MCV-C in infants and adolescents (MCV-C/C); (2) MCV-C in infants and MCV-4 in adolescents (MCV-C/4); and (3) MCV-4 in infants (2 doses) and adolescents (MCV-4/4). The source for IMD incidence was Canadian surveillance data. The effectiveness of MCV-C was based on published literature. The effectiveness of MCV-4 against all vaccination regimens was assumed to be the same as for MCV-C regimens against serogroup C. Herd effects were estimated by calibration to estimates reported in prior analyses. Costs were from published sources. Vaccines prices were projected to decline over time reflecting historical procurement trends. Results: Over the modeling horizon there are a projected 11,438 IMD cases and 1,195 IMD deaths with MCV-C/C; expected total costs are $597.5 million. MCV-C/4 is projected to reduce cases of IMD by 1,826 (16%) and IMD deaths by 161 (13%). Vaccination costs are increased by $32 million but direct and indirect IMD costs are projected to be reduced by $46 million. MCV-C/4 is therefore dominant vs. MCV-C/C in the base case. Cost-effectiveness of MCV-4/4 was $111,286 per QALY gained versus MCV-C/4 (2575/206 IMD cases/deaths prevented; incremental costs $68 million). Conclusions: If historical trends in Canadian vaccines prices continue, use of MCV-4 instead of MCV-C in adolescents may be cost-effective. From an economic perspective, switching to MCV-4 as the adolescent booster should be considered.

Suggested Citation

  • Thomas E Delea & Derek Weycker & Mark Atwood & Dion Neame & Fabián P Alvarez & Evelyn Forget & Joanne M Langley & Ayman Chit, 2017. "Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-17, May.
    • Handle: RePEc:plo:pone00:0175721
    DOI: 10.1371/journal.pone.0175721
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175721
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175721&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0175721?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Richard Pitman & David Fisman & Gregory S. Zaric & Maarten Postma & Mirjam Kretzschmar & John Edmunds & Marc Brisson, 2012. "Dynamic Transmission Modeling," Medical Decision Making, , vol. 32(5), pages 712-721, September.
    2. Chris T. Bauch & Andrea M. Anonychuk & Thierry Van Effelterre & Ba' Z. Pham & Maraki Fikre Merid, 2009. "Incorporating Herd Immunity Effects into Cohort Models of Vaccine Cost-Effectiveness," Medical Decision Making, , vol. 29(5), pages 557-569, September.
    3. repec:wbk:wbpubs:18237 is not listed on IDEAS
    4. Asian Development Bank (ADB), 2014. "Purchasing Power Parities and Real Expenditures," ADB Reports RPT146710-2, Asian Development Bank (ADB), revised 19 Aug 2014.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Tsiboe, Francis & Nalley, Lawton Lanier & Dixon, Bruce L. & Popp, Jennie S. & Luckstead, Jeff, 2014. "Cost-Benefit Analysis of the Cocoa Livelihoods Program in Sub-Saharan Africa," 2015 Annual Meeting, January 31-February 3, 2015, Atlanta, Georgia 195775, Southern Agricultural Economics Association.
    2. Axenciuc, Victor & Georgescu, George, 2017. "Gross Domestic Product – National Income of Romania 1862 – 2010. Secular statistical series and methodological foundations," MPRA Paper 84614, University Library of Munich, Germany.
    3. Jo-An Occhipinti & Danya Rose & Adam Skinner & Daniel Rock & Yun Ju C. Song & Ante Prodan & Sebastian Rosenberg & Louise Freebairn & Catherine Vacher & Ian B. Hickie, 2022. "Sound Decision Making in Uncertain Times: Can Systems Modelling Be Useful for Informing Policy and Planning for Suicide Prevention?," IJERPH, MDPI, vol. 19(3), pages 1-15, January.
    4. Georgescu, George, 2016. "The Gross Domestic Product. History, relevance and limitations in its interpretation," MPRA Paper 73644, University Library of Munich, Germany.
    5. Jamison Pike & Andrew J. Leidner & Harrell Chesson & Charles Stoecker & Scott D. Grosse, 2022. "Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines," Applied Health Economics and Health Policy, Springer, vol. 20(4), pages 457-465, July.
    6. Klas Kellerborg & Werner Brouwer & Pieter Baal, 2020. "Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1329-1350, December.
    7. repec:plo:pone00:0184179 is not listed on IDEAS
    8. Nora Lustig & Jacques Silber, 2016. "Global Poverty Lines: An Introduction," Working Papers 1603, Tulane University, Department of Economics.
    9. Matthew R Behrend & María-Gloria Basáñez & Jonathan I D Hamley & Travis C Porco & Wilma A Stolk & Martin Walker & Sake J de Vlas & for the NTD Modelling Consortium, 2020. "Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(4), pages 1-17, April.
    10. Chung, Seung-hun & Partridge, Mark, 2023. "Are short-term cultural shocks persistent? Taliban rule and long-run human capital accumulation," Journal of Economic Behavior & Organization, Elsevier, vol. 207(C), pages 18-49.
    11. Brooks, Douglas H. & Joshi, Kaushal & McArthur, John W. & Rhee, Changyong & Wan, Guanghua, 2014. "A ZEN approach to post-2015 development goals for Asia and the Pacific," Ecological Economics, Elsevier, vol. 107(C), pages 392-401.
    12. Angus Deaton & Bettina Aten, 2017. "Trying to Understand the PPPs in ICP 2011: Why Are the Results So Different?," American Economic Journal: Macroeconomics, American Economic Association, vol. 9(1), pages 243-264, January.
    13. Ravallion, Martin, 2018. "An exploration of the changes in the international comparison program’s global economic landscape," World Development, Elsevier, vol. 105(C), pages 201-216.
    14. Francisco H. G. Ferreira & Shaohua Chen & Andrew Dabalen & Yuri Dikhanov & Nada Hamadeh & Dean Jolliffe & Ambar Narayan & Espen Beer Prydz & Ana Revenga & Prem Sangraula & Umar Serajuddin & Nobuo Yosh, 2016. "A global count of the extreme poor in 2012: data issues, methodology and initial results," The Journal of Economic Inequality, Springer;Society for the Study of Economic Inequality, vol. 14(2), pages 141-172, June.
    15. Ashleigh R Tuite & Ann N Burchell & David N Fisman, 2014. "Cost-Effectiveness of Enhanced Syphilis Screening among HIV-Positive Men Who Have Sex with Men: A Microsimulation Model," PLOS ONE, Public Library of Science, vol. 9(7), pages 1-12, July.
    16. Kumar Gaurav & Nalin Bharti, 2018. "India–Japan CEPA," Foreign Trade Review, , vol. 53(3), pages 189-203, August.
    17. Koji Nomura & Kozo Miyagawa & Jon D. Samuels, 2018. "Benchmark 2011 Integrated Estimates of the Japan-U.S. Price Level Index for Industry Outputs," BEA Working Papers 0161, Bureau of Economic Analysis.
    18. Martin Ravallion, 2016. "Toward better global poverty measures," The Journal of Economic Inequality, Springer;Society for the Study of Economic Inequality, vol. 14(2), pages 227-248, June.
    19. Stephanie Popping & Sebastiaan J Hullegie & Anne Boerekamps & Bart J A Rijnders & Robert J de Knegt & Jürgen K Rockstroh & Annelies Verbon & Charles A B Boucher & Brooke E Nichols & David A M C van de, 2019. "Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-15, January.
    20. David Henderson, 2015. "Comparing Real GDP Across Countries: The Issues Revisited," Economic Affairs, Wiley Blackwell, vol. 35(2), pages 286-298, June.
    21. Amita Majumder & Ranjan Ray, 2015. "Estimates of Spatial Prices in India and their Sensitivity to Alternative Estimation Methods and Choice of Items," Monash Economics Working Papers 11-15, Monash University, Department of Economics.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0175721. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.